BORNCEFT-TZ is a modern combination antibacterial medication containing third-generation cephalosporin ceftriaxone and the beta-lactamase inhibitor tazobactam. This combination provides enhanced activity against a wide range of bacteria, including resistant strains.
Ceftriaxone works by inhibiting bacterial cell wall synthesis, leading to bacterial death. Tazobactam protects the antibiotic from bacterial enzyme destruction, increasing its effectiveness and expanding antimicrobial coverage.
Recommended for:
Clinical studies have demonstrated the effectiveness of ceftriaxone in treating complicated bacterial infections. The addition of tazobactam improves resistance coverage against beta-lactamase-producing organisms. The combination is widely used in hospital and outpatient settings due to its broad antibacterial spectrum.
The medication is indicated for the treatment of infections caused by susceptible bacteria. It is commonly used for lung infections, ENT infections, urinary tract infections, skin infections, abdominal infections, septic conditions, and postoperative bacterial complications. The drug helps suppress bacterial growth and eliminate infection.
The medication is administered intramuscularly or intravenously by a healthcare professional. Dosage and treatment duration depend on the severity of infection, patient condition, age, and kidney function. Self-administration without medical supervision is not recommended.
Side Effects
